CoChat

Oxidation and alkylation stresses activate ribosome-quality control

Open access

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Abstract

Oxidation and alkylation of nucleobases are known to disrupt their base-pairing properties within RNA. It is, however, unclear whether organisms have evolved general mechanism(s) to deal with this damage. Here we show that the mRNA-surveillance pathway of no-go decay and the associated ribosome-quality control are activated in response to nucleobase alkylation and oxidation. Our findings reveal that these processes are important for clearing chemically modified mRNA and the resulting aberrant-protein products. In the absence of Xrn1, the level of damaged mRNA significantly increases. Furthermore, deletion of LTN1 results in the accumulation of protein aggregates in the presence of oxidizing and alkylating agents. This accumulation is accompanied by Hel2-dependent regulatory ubiquitylation of ribosomal proteins. Collectively, our data highlight the burden of chemically damaged mRNA on cellular homeostasis and suggest that organisms evolved mechanisms to counter their accumulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-13579-3

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Oxidized and alkylated mRNAs accumulate in the absence of Xrn1. a A representative HPLC-ECD chromatogram used to quantify the concentration of 8-oxoG in our samples. b Bar graphs showing the ratio of 8-oxoG to G in total and polyA-RNA in presence and absence of Xrn1. c Bar graphs showing that the ratio of 8-oxoG to G in total and polyA-RNA significantly increases when 4-NQO is added to growing yeast cells. d Bar graphs demonstrating the ratio of the indicated alkylation adducts relative to their respective unmodified nucleoside in polyA-RNA in the presence and absence of Xrn1. e Same as d but in the absence and presence of MMS. In all cases, bars represent the average (±SD) of at least three independent biological replicates. Source data are provided as a Source Data file.
Fig. 1 Oxidized and alkylated mRNAs accumulate in the absence of Xrn1. a A representative HPLC-ECD chromatogram used to quantify the concentration of 8-oxoG in our samples. b Bar graphs showing the ratio of 8-oxoG to G in total and polyA-RNA in presence and absence of Xrn1. c Bar graphs showing that the ratio of 8-oxoG to G in total and polyA-RNA significantly increases when 4-NQO is added to growing yeast cells. d Bar graphs demonstrating the ratio of the indicated alkylation adducts relative to their respective unmodified nucleoside in polyA-RNA in the presence and absence of Xrn1. e Same as d but in the absence and presence of MMS. In all cases, bars represent the average (±SD) of at least three independent biological replicates. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Ubiquitinated-nascent peptides accumulate in the presence of the oxidizing agent 4-NQO. a A schematic showing the experimental setup used to assess the amount of nascent peptides in the ubiquitinated pool. After the addition of 4-NQO, cells are harvested, lysed, and puromycin is added to react with stalled ribosomes. TUBE beads are then used to bind ubiquitinated proteins. The purified proteins are separated using SDS–PAGE and probed with anti-puromycin antibody. b Western blot analysis of the input and TUBE-bound samples in the absence and presence of 4-NQO for the wild-type, cdc48-ts, ltn1Δ, and cdc48-ts;ltn1Δ cells. Note the signal for puromycin in the input sample is faint relative to that for ubiquitin. Black lines compare the WT sample in the absence of the drug with that in its presence at the permissive temperature. Red lines compare wild-type cells with the cdc48-ts ones in the presence of the drug under the restrictive conditions. Blue lines compare the cdc48-ts to cdc48-ts;ltn1Δ cells at the restrictive temperature.
Fig. 2 Ubiquitinated-nascent peptides accumulate in the presence of the oxidizing agent 4-NQO. a A schematic showing the experimental setup used to assess the amount of nascent peptides in the ubiquitinated pool. After the addition of 4-NQO, cells are harvested, lysed, and puromycin is added to react with stalled ribosomes. TUBE beads are then used to bind ubiquitinated proteins. The purified proteins are separated using SDS–PAGE and probed with anti-puromycin antibody. b Western blot analysis of the input and TUBE-bound samples in the absence and presence of 4-NQO for the wild-type, cdc48-ts, ltn1Δ, and cdc48-ts;ltn1Δ cells. Note the signal for puromycin in the input sample is faint relative to that for ubiquitin. Black lines compare the WT sample in the absence of the drug with that in its presence at the permissive temperature. Red lines compare wild-type cells with the cdc48-ts ones in the presence of the drug under the restrictive conditions. Blue lines compare the cdc48-ts to cdc48-ts;ltn1Δ cells at the restrictive temperature.CC BY · PubMed Central
Fig. 3 The addition of damaging agents leads to the accumulation of Hsp104-mCherry foci in the absence of Ltn1 and Hel2. a Representative images of the indicated cells in the absence and presence of MMS. Shown are brightfield, mCherry and DAPI signals. Scale bar is 10 μm. b Bar graph showing the quantification of cells with >1 focus in the presence of the specified drugs for WT and ltn1Δ cells. c Similar to b, using WT and hel2Δ cells. d Bar graph used to show the consequence of a cycloheximide pre-treatment on the effect of MMS on foci formation. In all cases, the average foci count of at least three biological repeats is plotted with the error bars representing the standard deviation around the mean. For each biological repeat, > 120 cells were counted. Source data are provided as a Source Data file.
Fig. 3 The addition of damaging agents leads to the accumulation of Hsp104-mCherry foci in the absence of Ltn1 and Hel2. a Representative images of the indicated cells in the absence and presence of MMS. Shown are brightfield, mCherry and DAPI signals. Scale bar is 10 μm. b Bar graph showing the quantification of cells with >1 focus in the presence of the specified drugs for WT and ltn1Δ cells. c Similar to b, using WT and hel2Δ cells. d Bar graph used to show the consequence of a cycloheximide pre-treatment on the effect of MMS on foci formation. In all cases, the average foci count of at least three biological repeats is plotted with the error bars representing the standard deviation around the mean. For each biological repeat, > 120 cells were counted. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 Ribosomal proteins are ubiquitinylated by Hel2 in the presence of damaging agents. a Western blot analysis of ubiquitinated proteins in total lysates and ribosome fractions in the presence of the indicated compounds. b Release of nascent peptides by puromycin does not affect the ubiquitination pattern of proteins in the ribosome fraction. Right panel is a western analysis of the puromycylation reactions under the indicated conditions. Left panel is a western analysis of ubiquitination of ribosome-enriched fraction in the presence and absence of puromycin upon the addition of 4-NQO. c Western-bot analysis showing that the ubiquitination of ribosomal proteins after MMS addition is completely inhibited when HEL2 is deleted. d Western blot analysis used to assess the relative amount of ubiquitinated ribosomal proteins in the presence of 4-NQO when eIF4E, and hence initiation, is inactivated. Lines compare WT and cdc33-ts cells in the presence of 4-NQO at the restrictive temperature. e Sucrose-gradient fractionation of lysates obtained from endogenous HEL2: 3 × FLAG tag yeast cells in the absence and presence of 4-NQO. The traces follow the absorbance at 254 nm, below the traces is the western blot analysis of the fractions using anti-FLAG antibody. f Heat map showing scaled ubiquitination footprints of ribosome and ubiquitin-derived peptides in response to 4-NQO. The samples were digested with trypsin and enriched for diGly, prior to tandem MS analysis. Two independent biological replicates are shown and the modified lysine residues are indicated to the right of the ribosomal protein name. The peptides are organized based on their origin and subsequently ranked by their response to 4-NQO. g Bar graph showing the relative abundance of ubiquitin (eS31) and different ubiquitin chains. h–k Bar graphs showing the relative abundance of corresponding ribosomal proteins (on the left) and diGly modified peptides (on the right) in the absence and presence of 4-NQO (In all cases n = 2, ±SD). l–m Western blot analysis used to follow the ubiquitination of depicted ribosomal proteins in the presence of the indicated compounds. A C-terminal FLAG tag was added to the chromosomal copy of ribosomal protein genes. Source data are provided as a Source Data file.
Fig. 4 Ribosomal proteins are ubiquitinylated by Hel2 in the presence of damaging agents. a Western blot analysis of ubiquitinated proteins in total lysates and ribosome fractions in the presence of the indicated compounds. b Release of nascent peptides by puromycin does not affect the ubiquitination pattern of proteins in the ribosome fraction. Right panel is a western analysis of the puromycylation reactions under the indicated conditions. Left panel is a western analysis of ubiquitination of ribosome-enriched fraction in the presence and absence of puromycin upon the addition of 4-NQO. c Western-bot analysis showing that the ubiquitination of ribosomal proteins after MMS addition is completely inhibited when HEL2 is deleted. d Western blot analysis used to assess the relative amount of ubiquitinated ribosomal proteins in the presence of 4-NQO when eIF4E, and hence initiation, is inactivated. Lines compare WT and cdc33-ts cells in the presence of 4-NQO at the restrictive temperature. e Sucrose-gradient fractionation of lysates obtained from endogenous HEL2: 3 × FLAG tag yeast cells in the absence and presence of 4-NQO. The traces follow the absorbance at 254 nm, below the traces is the western blot analysis of the fractions using anti-FLAG antibody. f Heat map showing scaled ubiquitination footprints of ribosome and ubiquitin-derived peptides in response to 4-NQO. The samples were digested with trypsin and enriched for diGly, prior to tandem MS analysis. Two independent biological replicates are shown and the modified lysine residues are indicated to the right of the ribosomal protein name. The peptides are organized based on their origin and subsequently ranked by their response to 4-NQO. g Bar graph showing the relative abundance of ubiquitin (eS31) and different ubiquitin chains. h–k Bar graphs showing the relative abundance of corresponding ribosomal proteins (on the left) and diGly modified peptides (on the right) in the absence and presence of 4-NQO (In all cases n = 2, ±SD). l–m Western blot analysis used to follow the ubiquitination of depicted ribosomal proteins in the presence of the indicated compounds. A C-terminal FLAG tag was added to the chromosomal copy of ribosomal protein genes. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 Agents that strictly compromise the integrity of DNA do not lead to ribosomal proteins ubiquitination. a Western blot analysis of ribosomal protein ubiquitination and uS3 in the presence of the indicated compounds. Phosphorylation of H2AX was used to assess the activation of the DNA-damage response. b Western blot analysis of ribosomal proteins ubiquitination as a function of increasing cisplatin concentrations. c Western blot analysis of ribosomal protein ubiquitination and H2AX phosphorylation as a function of time after the addition 4-NQO. Note ribosomal protein ubiquitination is observed only after 5 min of incubation and saturates at the ten-minute mark. In contrast, γ-H2AX signal appears not to near saturation after 45 min of incubation. Source data are provided as a Source Data file.
Fig. 5 Agents that strictly compromise the integrity of DNA do not lead to ribosomal proteins ubiquitination. a Western blot analysis of ribosomal protein ubiquitination and uS3 in the presence of the indicated compounds. Phosphorylation of H2AX was used to assess the activation of the DNA-damage response. b Western blot analysis of ribosomal proteins ubiquitination as a function of increasing cisplatin concentrations. c Western blot analysis of ribosomal protein ubiquitination and H2AX phosphorylation as a function of time after the addition 4-NQO. Note ribosomal protein ubiquitination is observed only after 5 min of incubation and saturates at the ten-minute mark. In contrast, γ-H2AX signal appears not to near saturation after 45 min of incubation. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 Mutations in NGD and RQC components render cells sensitive to 4-NQO and MMS addition. a Top is a plot of OD600nm over time of the indicated strains after a mock treatment or a 30-minute challenge with 4-NQO (1 μg/mL) or MMS (0.1% MMS). Bottom is a plot of the first derivative of the data on top to calculate the instantaneous growth rate and the corresponding lag time needed to reach the maximum rate. Data were collected in technical duplicates from three biological replicates. b A bar graph showing the determined lag time from a. The mean of three biological replicates is plotted and the error bars represent the standard deviation. p value from two-way ANOVA test is indicated. Source data are provided as a Source Data file. c Images of spot assays performed using the indicated strains, after mock treatment or a 30-minute challenge using 4-NQO (1 μg/mL) or MMS (0.1% MMS).
Fig. 6 Mutations in NGD and RQC components render cells sensitive to 4-NQO and MMS addition. a Top is a plot of OD600nm over time of the indicated strains after a mock treatment or a 30-minute challenge with 4-NQO (1 μg/mL) or MMS (0.1% MMS). Bottom is a plot of the first derivative of the data on top to calculate the instantaneous growth rate and the corresponding lag time needed to reach the maximum rate. Data were collected in technical duplicates from three biological replicates. b A bar graph showing the determined lag time from a. The mean of three biological replicates is plotted and the error bars represent the standard deviation. p value from two-way ANOVA test is indicated. Source data are provided as a Source Data file. c Images of spot assays performed using the indicated strains, after mock treatment or a 30-minute challenge using 4-NQO (1 μg/mL) or MMS (0.1% MMS).CC BY · PubMed Central
Fig. 7 The presence of one 8-oxoG adduct in the ORF of an mRNA leads to accelerated rate of decay in HEK293 cells. a Schematic showing the steps used to make mRNA reporters with 8-oxoG in the ORF. b Ethidium-bromide-stained PAGE gel used to follow the construction of the mRNA showing that they migrate as would be predicted based on their size. c Microscope images of HEK293 cells electroporated with capped and uncapped eGFP mRNA used to assess electroporation efficiency. Shown are the brightfield, and GFP- and DAPI-fluorescence signals. Scale bar is 50 μm. d Northern analysis to measure the decay of the indicated reporters and the control GFP mRNAs post electroporation. Reporters were visualized directly by exposing the nylon transfer to a phosphorimager screen. GFP and GAPDH were visualized using a radiolabeled DNA probe. At the bottom is the ethidium-bromide stained agarose gel. The half-lives were determined from duplicates (±SD).
Fig. 7 The presence of one 8-oxoG adduct in the ORF of an mRNA leads to accelerated rate of decay in HEK293 cells. a Schematic showing the steps used to make mRNA reporters with 8-oxoG in the ORF. b Ethidium-bromide-stained PAGE gel used to follow the construction of the mRNA showing that they migrate as would be predicted based on their size. c Microscope images of HEK293 cells electroporated with capped and uncapped eGFP mRNA used to assess electroporation efficiency. Shown are the brightfield, and GFP- and DAPI-fluorescence signals. Scale bar is 50 μm. d Northern analysis to measure the decay of the indicated reporters and the control GFP mRNAs post electroporation. Reporters were visualized directly by exposing the nylon transfer to a phosphorimager screen. GFP and GAPDH were visualized using a radiolabeled DNA probe. At the bottom is the ethidium-bromide stained agarose gel. The half-lives were determined from duplicates (±SD).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 97 references

Cited by

See all 132

Metadata

Authors
Yan, L. L., Simms, C. L., McLoughlin, F., Vierstra, R. D., & Zaher, H. S.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Zaher, Hani S.
Venue
Nature Communications
Published
2019-12-09
Volume
10
Issue
1
Pages
5611-5611
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2993298108
Cited by
123
References
96
Citations by year
2026: 16 · 2025: 19 · 2024: 31 · 2023: 21 · 2022: 9 · 2021: 14 · 2020: 12 · 2019: 1
FWCI
2.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM112641)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Keywords
ribosome-associated quality control, no-go decay, mRNA surveillance, nucleobase oxidation, chemically modified mRNA, Xrn1, Ltn1, protein aggregates
MeSH terms
Alkylation, DNA Damage, Humans, Methyl Methanesulfonate, Mutation, Oxidation-Reduction, Peptides, Polyribosomes, Ribosomal Proteins, Ribosomes, RNA, Messenger, Saccharomyces cerevisiae, 4-Nitroquinoline-1-oxide, Quinolones, Oxidative Stress, DNA Adducts, RNA Stability, Ubiquitin, Saccharomyces cerevisiae Proteins, Ubiquitin-Protein Ligases, Ubiquitination, HEK293 Cells, Protein Aggregates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oxidation and alkylation stresses activate ribosome-quality control. https://app.cochat.ai/papers/10.1038/s41467-019-13579-3
The paper
Yan, L. L., Simms, C. L., McLoughlin, F., Vierstra, R. D., & Zaher, H. S. (2019). Oxidation and alkylation stresses activate ribosome-quality control. Nature Communications. https://doi.org/10.1038/s41467-019-13579-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.